Equities

European Medical Solutions

European Medical Solutions

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)0.0198
  • Today's Change0.00 / 0.00%
  • Shares traded12.82k
  • 1 Year change+20.00%
  • Beta0.7033
Data delayed at least 15 minutes, as of Jun 28 2024 13:46 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

European Medical Solutions is a Belgium-based company which is mainly focused on technological medical imaging solutions. The Company offers a complete range of medical imaging systems on the international market. It specializes in the design and manufacture of imaging systems for digital and conventional radiology and bone densitometry. It offers products such as: radiology equipment (mobile radiology units, floating panel tables, mobile C-arm for operating room, etc.), ultrasound bone densitometers (for the reconstruction of bone microarchitecture), X-ray bone densitometers (for the measurement of bone density), etc.

  • Revenue in EUR (TTM)40.56m
  • Net income in EUR-709.00k
  • Incorporated1997
  • Employees124.00
  • Location
    European Medical SolutionsAvenue Louise 231BRUXELLES 1050BelgiumBEL
  • Phone+32 467504900
  • Fax+32 467504909
  • Websitehttps://www.dms-imaging.com/
More ▼

Institutional shareholders

0.02%Per cent of shares held by top holders
HolderShares% Held
Lemanik Asset Management SAas of 30 Jun 2023241.80k0.02%
Data from 30 Apr 2024 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.